Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anna K. Schneider"'
Autor:
Anna K. Schneider, Sonia Domingos-Pereira, Valérie Cesson, Lenka Polak, Padraic G. Fallon, Jinfang Zhu, Beat Roth, Denise Nardelli-Haefliger, Laurent Derré
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Therapies for bladder cancer patients are limited by side effects and failures, highlighting the need for novel targets to improve disease management. Given the emerging evidence highlighting the key role of innate lymphoid cell subsets, especially t
Externí odkaz:
https://doaj.org/article/66a6e962b7b944c5b7fdeb9717b0bc58
Autor:
Sulayman Benmerzoug, Mathieu F. Chevalier, Laura Villier, Sylvain Nguyen, Valérie Cesson, Anna K. Schneider, Florence Dartiguenave, Sonia-Christina Rodrigues-Dias, Ilaria Lucca, Patrice Jichlinski, Beat Roth, Denise Nardelli-Haefliger, Laurent Derré
Publikováno v:
European Urology Open Science, Vol 34, Iss , Pp 79-82 (2021)
Aberrant glycosylation actively contributes to tumor progression and is a key hallmark of cancer. Most of the glycan moieties expressed on the surface of cancer cells are sialic acids that may modulate antitumor immune responses via binding to sialic
Externí odkaz:
https://doaj.org/article/66cfbf05dc5a4c1abdec773b93fd4a9e
Autor:
Mathieu Rouanne, Julien Adam, Camélia Radulescu, Diane Letourneur, Delphine Bredel, Séverine Mouraud, Anne-Gaëlle Goubet, Marion Leduc, Noah Chen, Tuan Zea Tan, Nicolas Signolle, Amélie Bigorgne, Michael Dussiot, Lambros Tselikas, Sandrine Susini, François-Xavier Danlos, Anna K. Schneider, Roman Chabanon, Sophie Vacher, Ivan Bièche, Thierry Lebret, Yves Allory, Jean-Charles Soria, Nicholas Arpaia, Guido Kroemer, Oliver Kepp, Jean Paul Thiery, Laurence Zitvogel, Aurélien Marabelle
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 12 (2022)
Patients with high-risk, nonmuscle-invasive bladder cancer (NMIBC) frequently relapse after standard intravesical bacillus Calmette-Guérin (BCG) therapy and may have a dismal outcome. The mechanisms of resistance to such immunotherapy remain poorly
Externí odkaz:
https://doaj.org/article/d3133523389b44ef89a70120d1393a04
Autor:
Denise Nardelli-Haefliger, Laurent Derré, Sylvain Nguyen, Mathieu F Chevalier, Sulayman Benmerzoug, Valérie Cesson, Anna K Schneider, Sonia-Cristina Rodrigues-Dias, Florence Dartiguenave, Ilaria Lucca, Patrice Jichlinski, Beat Roth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 8 (2022)
Background Bladder cancer is an important public health concern due to its prevalence, high risk of recurrence and associated cost of management. Although BCG instillation for urothelial cancer treatment is the gold-standard treatment for this indica
Externí odkaz:
https://doaj.org/article/e60e18220c004a3b882e44233badf480
Autor:
Valérie Cesson, Beat Roth, Sylvain Nguyen, Florence Dartiguenave, Sulayman Benmerzoug, Denise Nardelli-Haefliger, Mathieu F. Chevalier, Laurent Derré, Sonia-Christina Rodrigues-Dias, Ilaria Lucca, Anna K. Schneider, Patrice Jichlinski, Maëlle Verardo
Publikováno v:
European Urology Focus. 8:748-751
Among the growing family of inhibitory receptors regulating immunity, sialic acid-binding immunoglobulin domain-containing lectins (Siglecs) have recently emerged as immunoregulatory receptors recognizing sialylated ligands on tumor cell surface. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f6f8f79a232106e4584557a7db7439
https://doi.org/10.1016/j.euf.2021.06.001
https://doi.org/10.1016/j.euf.2021.06.001
Autor:
Valérie Cesson, Laurent Derré, Laura Villier, Beat Roth, Sulayman Benmerzoug, Anna K. Schneider, Patrice Jichlinski, Ilaria Lucca, Denise Nardelli-Haefliger, Mathieu F. Chevalier, Sylvain Nguyen, Sonia-Christina Rodrigues-Dias, Florence Dartiguenave
Publikováno v:
European Urology Open Science
European urology open science, vol. 34, pp. 79-82
European Urology Open Science, Vol 34, Iss, Pp 79-82 (2021)
European urology open science, vol. 34, pp. 79-82
European Urology Open Science, Vol 34, Iss, Pp 79-82 (2021)
Aberrant glycosylation actively contributes to tumor progression and is a key hallmark of cancer. Most of the glycan moieties expressed on the surface of cancer cells are sialic acids that may modulate antitumor immune responses via binding to sialic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b15877383e1713eea5a3655c6cb85e
http://europepmc.org/articles/PMC8605422
http://europepmc.org/articles/PMC8605422
Autor:
Mathieu Rouanne, Julien Adam, Camélia Radulescu, Diane Letourneur, Delphine Bredel, Séverine Mouraud, Anne-Gaëlle Goubet, Marion Leduc, Noah Chen, Tuan Zea Tan, Nicolas Signolle, Amélie Bigorgne, Michael Dussiot, Lambros Tselikas, Sandrine Susini, François-Xavier Danlos, Anna K. Schneider, Roman Chabanon, Sophie Vacher, Ivan Bièche, Thierry Lebret, Yves Allory, Jean-Charles Soria, Nicholas Arpaia, Guido Kroemer, Oliver Kepp, Jean Paul Thiery, Laurence Zitvogel, Aurélien Marabelle
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, 2022, 132 (12), pp.e145666. ⟨10.1172/JCI145666⟩
Journal of Clinical Investigation, 2022, 132 (12), pp.e145666. ⟨10.1172/JCI145666⟩
International audience; Patients with high-risk, nonmuscle-invasive bladder cancer (NMIBC) frequently relapse after standard intravesical bacillus Calmette-Guérin (BCG) therapy and may have a dismal outcome. The mechanisms of resistance to such immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03f182ed7661c424a1016d7d86c1cb28
https://pubmed.ncbi.nlm.nih.gov/35503263
https://pubmed.ncbi.nlm.nih.gov/35503263
Autor:
Michael Dussiot, Sophie Vacher, Severine Mouraud, Yves Allory, Aurélien Marabelle, Lambros Tselikas, Roman M. Chabanon, Diane Letourneur, Anne-Gaëlle Goubet, Anna K. Schneider, Jean-Charles Soria, Mathieu Rouanne, Sandrine Susini, Ivan Bièche, François-Xavier Danlos, Jean Paul Thiery, Amélie Bigorgne, Delphine Bredel, Camelia Radulescu, Julien Adam, Laurence Zitvogel, Tuan Zea Tan, Nicolas Signolle, Thierry Lebret
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPatients with high-risk non muscle-invasive bladder cancer (NMIBC) frequently relapse after standard BCG immunotherapy and have a dismal outcome after progression to muscle-invasive bladder cancer (MIBC).1 2 The mechanisms of tumor resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8378ca56328c1087c76bf7e9c371a968
https://doi.org/10.1136/jitc-2021-sitc2021.901
https://doi.org/10.1136/jitc-2021-sitc2021.901
Autor:
Jean Paul Thiery, Amélie Bigorgne, Michael Dussiot, Thierry Lebret, Delphine Bredel, Diane Letourneur, Lambros Tselikas, Laurence Zitvogel, Mathieu Rouanne, Ivan Bièche, Tuan Zea Tan, Jean-Charles Soria, Camelia Radulescu, Julien Adam, Severine Mouraud, Yves Allory, Roman M. Chabanon, Anna K. Schneider, Aurélien Marabelle, Sandrine Susini, François-Xavier Danlos, Nicolas Signolle, Sophie Vacher
Publikováno v:
Cancer Research. 81:66-66
Patients with high-risk non muscle-invasive bladder cancer (NMIBC) frequently relapse after standard BCG immunotherapy and have a dismal outcome after progression to muscle-invasive bladder cancer (MIBC). The mechanisms of tumor resistance to such im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56682e4ea747a90a1a34d2c446efb88d
https://doi.org/10.1158/1538-7445.am2021-66
https://doi.org/10.1158/1538-7445.am2021-66
Publikováno v:
Nature reviews. Urology. 16(10)
Bladder cancer is an important public health concern owing to its prevalence, high recurrence risk and treatment failures. Maintaining the equilibrium between prompt and effective immunity and an excessive and protracted immune response is critical f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::396cf699998c13eea4ef6b2dd6876585
https://pubmed.ncbi.nlm.nih.gov/31501534
https://pubmed.ncbi.nlm.nih.gov/31501534